115 related articles for article (PubMed ID: 6338975)
1. Analysis of human myelogenous leukemia cells in the fluorescence-activated cell sorter using a tumor-specific antiserum.
Malcolm AJ; Logan PM; Shipman RC; Kurth R; Levy JG
Blood; 1983 May; 61(5):858-66. PubMed ID: 6338975
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to myelogenous leukemia: isolation and characterization.
Malcolm AJ; Shipman RC; Logan PM; Levy JG
Exp Hematol; 1984 Aug; 12(7):539-47. PubMed ID: 6589167
[TBL] [Abstract][Full Text] [Related]
3. Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.
Malcolm AJ; Shipman RC; Levy JG
J Immunol; 1982 Jun; 128(6):2599-603. PubMed ID: 7042842
[TBL] [Abstract][Full Text] [Related]
4. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
Andreasen RB; Olsson L
J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
[TBL] [Abstract][Full Text] [Related]
5. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
Metzgar RS; Mohanakumar T; Bolognesi DP
J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
7. Specificity of heteroantisera to human acute leukemia-associated antigens.
Baker MA; Ramachandar K; Taub RN
J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
[TBL] [Abstract][Full Text] [Related]
8. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
[TBL] [Abstract][Full Text] [Related]
9. Detection of a common leukemia-associated antigen in human myelogenous leukemia using immunoperoxidase.
Logan PM; Malcolm AJ; Levy JG
Diagn Immunol; 1984; 2(2):86-100. PubMed ID: 6238754
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique.
Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD
Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
12. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
[TBL] [Abstract][Full Text] [Related]
14. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping of acute myelocytic leukemia (AML) progenitors: an approach for tracing minimal numbers of AML cells among normal bone marrow.
Delwel R; van Gurp R; Bot F; Touw I; Löwenberg B
Leukemia; 1988 Dec; 2(12):814-9. PubMed ID: 3199876
[TBL] [Abstract][Full Text] [Related]
16. NHL-30.5: a monoclonal antibody reactive with an acute myeloid leukemia (AML)-associated antigen.
Askew DS; Eaves AC; Takei F
Leuk Res; 1985; 9(1):135-45. PubMed ID: 3857404
[TBL] [Abstract][Full Text] [Related]
17. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphocytic leukemia-associated cell membrane antigen.
Billing R; Minowada J; Cline M; Clark B; Lee K
J Natl Cancer Inst; 1978 Aug; 61(2):423-9. PubMed ID: 308102
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
[TBL] [Abstract][Full Text] [Related]
20. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
